Concepts (285)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms | 29 | 2022 | 1033 | 3.970 |
Why?
|
Uterine Cervical Neoplasms | 10 | 2023 | 248 | 2.740 |
Why?
|
Breast Neoplasms | 16 | 2021 | 1426 | 2.660 |
Why?
|
Colorectal Neoplasms | 8 | 2023 | 413 | 2.330 |
Why?
|
Early Detection of Cancer | 12 | 2023 | 292 | 2.310 |
Why?
|
Health Knowledge, Attitudes, Practice | 19 | 2021 | 790 | 2.010 |
Why?
|
Humans | 95 | 2024 | 34853 | 1.690 |
Why?
|
Language | 6 | 2018 | 143 | 1.620 |
Why?
|
Mass Screening | 7 | 2021 | 427 | 1.610 |
Why?
|
Clinical Trials as Topic | 7 | 2018 | 195 | 1.580 |
Why?
|
Female | 67 | 2023 | 19873 | 1.540 |
Why?
|
HIV Infections | 5 | 2023 | 2207 | 1.530 |
Why?
|
Continuity of Patient Care | 8 | 2022 | 90 | 1.500 |
Why?
|
Psychometrics | 12 | 2023 | 292 | 1.360 |
Why?
|
Biological Specimen Banks | 4 | 2018 | 21 | 1.340 |
Why?
|
Patient Education as Topic | 4 | 2015 | 207 | 1.340 |
Why?
|
Anti-HIV Agents | 2 | 2023 | 394 | 1.310 |
Why?
|
Health Services Accessibility | 13 | 2015 | 531 | 1.290 |
Why?
|
Adult | 42 | 2023 | 11034 | 1.290 |
Why?
|
Middle Aged | 45 | 2023 | 9642 | 1.260 |
Why?
|
Healthcare Disparities | 11 | 2017 | 446 | 1.200 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2017 | 31 | 1.180 |
Why?
|
Self Efficacy | 8 | 2018 | 173 | 1.160 |
Why?
|
Male | 45 | 2023 | 18870 | 1.140 |
Why?
|
Patient Satisfaction | 9 | 2019 | 141 | 1.090 |
Why?
|
Patient Acceptance of Health Care | 7 | 2021 | 375 | 1.030 |
Why?
|
Papillomavirus Vaccines | 3 | 2021 | 136 | 1.010 |
Why?
|
Papillomavirus Infections | 4 | 2021 | 316 | 0.980 |
Why?
|
Breast Feeding | 3 | 2013 | 105 | 0.860 |
Why?
|
Internal-External Control | 2 | 2018 | 47 | 0.860 |
Why?
|
Biomedical Research | 5 | 2022 | 371 | 0.830 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 99 | 0.800 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 37 | 0.800 |
Why?
|
Florida | 11 | 2018 | 358 | 0.780 |
Why?
|
Patient Advocacy | 3 | 2017 | 20 | 0.780 |
Why?
|
Attitude | 4 | 2016 | 97 | 0.760 |
Why?
|
Young Adult | 18 | 2023 | 4012 | 0.750 |
Why?
|
Health Personnel | 3 | 2018 | 200 | 0.740 |
Why?
|
Mental Disorders | 1 | 2023 | 285 | 0.740 |
Why?
|
Aged | 24 | 2023 | 6448 | 0.730 |
Why?
|
Patient Participation | 4 | 2013 | 68 | 0.720 |
Why?
|
United States | 18 | 2022 | 3894 | 0.710 |
Why?
|
Health Education | 5 | 2020 | 304 | 0.700 |
Why?
|
Vulnerable Populations | 2 | 2017 | 132 | 0.690 |
Why?
|
Health Status Disparities | 4 | 2014 | 583 | 0.690 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2024 | 58 | 0.670 |
Why?
|
Heterosexuality | 1 | 2019 | 85 | 0.670 |
Why?
|
Adolescent | 15 | 2021 | 5035 | 0.660 |
Why?
|
Multimedia | 3 | 2013 | 16 | 0.660 |
Why?
|
Mammography | 2 | 2011 | 176 | 0.650 |
Why?
|
Skin Neoplasms | 3 | 2017 | 151 | 0.640 |
Why?
|
Social Support | 7 | 2022 | 356 | 0.630 |
Why?
|
Famous Persons | 1 | 2017 | 5 | 0.630 |
Why?
|
Mastectomy | 1 | 2017 | 19 | 0.630 |
Why?
|
Research Subjects | 2 | 2018 | 31 | 0.620 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2017 | 20 | 0.620 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 20 | 0.620 |
Why?
|
Disclosure | 1 | 2017 | 31 | 0.610 |
Why?
|
Anxiety | 4 | 2023 | 705 | 0.590 |
Why?
|
Primary Health Care | 2 | 2018 | 283 | 0.580 |
Why?
|
Melanoma | 1 | 2017 | 91 | 0.570 |
Why?
|
Medication Adherence | 2 | 2016 | 165 | 0.560 |
Why?
|
Mental Health | 1 | 2019 | 270 | 0.560 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2022 | 592 | 0.550 |
Why?
|
Rural Population | 2 | 2015 | 253 | 0.550 |
Why?
|
Quality of Health Care | 3 | 2014 | 136 | 0.550 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 176 | 0.550 |
Why?
|
Inservice Training | 1 | 2015 | 30 | 0.550 |
Why?
|
Caregivers | 3 | 2022 | 167 | 0.540 |
Why?
|
Qualitative Research | 5 | 2019 | 393 | 0.540 |
Why?
|
Trust | 1 | 2016 | 119 | 0.530 |
Why?
|
RNA Splice Sites | 1 | 2015 | 10 | 0.530 |
Why?
|
RNA Splicing | 1 | 2015 | 36 | 0.520 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 2561 | 0.520 |
Why?
|
Computers | 1 | 2015 | 27 | 0.520 |
Why?
|
India | 3 | 2019 | 82 | 0.520 |
Why?
|
Sunburn | 2 | 2011 | 4 | 0.520 |
Why?
|
Minority Health | 2 | 2022 | 81 | 0.520 |
Why?
|
Reproducibility of Results | 7 | 2023 | 901 | 0.510 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2015 | 40 | 0.510 |
Why?
|
Caenorhabditis elegans | 1 | 2015 | 74 | 0.490 |
Why?
|
Delivery of Health Care | 4 | 2022 | 254 | 0.490 |
Why?
|
Regional Health Planning | 1 | 2013 | 14 | 0.490 |
Why?
|
Community Health Centers | 2 | 2012 | 45 | 0.480 |
Why?
|
Focus Groups | 4 | 2019 | 307 | 0.470 |
Why?
|
Tissue and Organ Procurement | 1 | 2014 | 43 | 0.470 |
Why?
|
Software | 1 | 2015 | 204 | 0.460 |
Why?
|
Vaginal Smears | 3 | 2019 | 52 | 0.450 |
Why?
|
Intention | 4 | 2018 | 84 | 0.440 |
Why?
|
Rural Health Services | 1 | 2012 | 39 | 0.440 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 28 | 0.430 |
Why?
|
Depression | 4 | 2019 | 664 | 0.430 |
Why?
|
Decision Making | 4 | 2017 | 189 | 0.410 |
Why?
|
Interviews as Topic | 3 | 2019 | 356 | 0.400 |
Why?
|
Research Design | 2 | 2011 | 292 | 0.380 |
Why?
|
Socioeconomic Factors | 7 | 2018 | 1003 | 0.380 |
Why?
|
Schools | 1 | 2011 | 229 | 0.370 |
Why?
|
Transcription Factors | 1 | 2015 | 653 | 0.370 |
Why?
|
Allied Health Personnel | 1 | 2009 | 7 | 0.350 |
Why?
|
Telephone | 1 | 2009 | 32 | 0.350 |
Why?
|
Motivation | 3 | 2017 | 415 | 0.350 |
Why?
|
Internet | 2 | 2023 | 204 | 0.350 |
Why?
|
Transients and Migrants | 2 | 2021 | 25 | 0.340 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 47 | 0.330 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2008 | 26 | 0.330 |
Why?
|
Diabetes Complications | 1 | 2009 | 91 | 0.330 |
Why?
|
Medical Oncology | 3 | 2022 | 26 | 0.330 |
Why?
|
Survivors | 2 | 2021 | 126 | 0.320 |
Why?
|
Quality of Life | 3 | 2021 | 459 | 0.310 |
Why?
|
Self Care | 1 | 2009 | 150 | 0.310 |
Why?
|
Communication | 3 | 2019 | 170 | 0.310 |
Why?
|
Neurons | 1 | 2015 | 1130 | 0.310 |
Why?
|
Pregnancy | 4 | 2022 | 1503 | 0.300 |
Why?
|
Homosexuality, Male | 2 | 2023 | 438 | 0.290 |
Why?
|
Attitude to Health | 4 | 2014 | 311 | 0.290 |
Why?
|
Protective Clothing | 3 | 2011 | 7 | 0.290 |
Why?
|
Immunization Programs | 3 | 2000 | 22 | 0.290 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 233 | 0.280 |
Why?
|
Adaptation, Psychological | 1 | 2009 | 358 | 0.280 |
Why?
|
Aged, 80 and over | 9 | 2020 | 2333 | 0.280 |
Why?
|
Vaccination | 3 | 2021 | 259 | 0.260 |
Why?
|
Factor Analysis, Statistical | 3 | 2018 | 125 | 0.250 |
Why?
|
Registries | 3 | 2000 | 330 | 0.250 |
Why?
|
Insulin-Secreting Cells | 1 | 2023 | 27 | 0.240 |
Why?
|
Pilot Projects | 3 | 2021 | 628 | 0.240 |
Why?
|
Alternative Splicing | 1 | 2023 | 82 | 0.240 |
Why?
|
Mexico | 1 | 2023 | 223 | 0.220 |
Why?
|
Cation Transport Proteins | 1 | 2022 | 30 | 0.220 |
Why?
|
Interpersonal Relations | 3 | 2019 | 198 | 0.220 |
Why?
|
Islets of Langerhans | 1 | 2021 | 9 | 0.210 |
Why?
|
Community Networks | 2 | 2013 | 98 | 0.210 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2022 | 67 | 0.210 |
Why?
|
Virginia | 1 | 2021 | 9 | 0.210 |
Why?
|
Infant | 2 | 2022 | 1014 | 0.200 |
Why?
|
Mexican Americans | 1 | 2023 | 177 | 0.200 |
Why?
|
Risk Factors | 4 | 2017 | 3414 | 0.200 |
Why?
|
Demography | 1 | 2021 | 167 | 0.200 |
Why?
|
Perception | 2 | 2012 | 183 | 0.190 |
Why?
|
Follow-Up Studies | 5 | 2015 | 964 | 0.190 |
Why?
|
Mothers | 1 | 2022 | 164 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 133 | 0.190 |
Why?
|
Blogging | 1 | 2019 | 2 | 0.190 |
Why?
|
Brain Neoplasms | 1 | 2021 | 105 | 0.180 |
Why?
|
Ultraviolet Rays | 2 | 2017 | 116 | 0.170 |
Why?
|
Spouses | 1 | 2019 | 29 | 0.170 |
Why?
|
Time Factors | 5 | 2015 | 1681 | 0.170 |
Why?
|
Stereotyping | 1 | 2019 | 40 | 0.170 |
Why?
|
Fatigue | 1 | 2019 | 79 | 0.170 |
Why?
|
Puerto Rico | 2 | 2013 | 1352 | 0.170 |
Why?
|
Child | 7 | 2021 | 2875 | 0.170 |
Why?
|
Cultural Competency | 2 | 2018 | 120 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2018 | 196 | 0.160 |
Why?
|
Condoms | 1 | 2019 | 132 | 0.160 |
Why?
|
Sunbathing | 1 | 2017 | 6 | 0.160 |
Why?
|
Needs Assessment | 2 | 2013 | 159 | 0.150 |
Why?
|
Awareness | 1 | 2017 | 59 | 0.150 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 186 | 0.150 |
Why?
|
Models, Psychological | 1 | 2017 | 120 | 0.150 |
Why?
|
Genetic Testing | 1 | 2017 | 71 | 0.150 |
Why?
|
Chronic Disease | 2 | 2020 | 469 | 0.150 |
Why?
|
Videodisc Recording | 2 | 2013 | 3 | 0.150 |
Why?
|
Program Evaluation | 2 | 2015 | 316 | 0.150 |
Why?
|
Patient Selection | 2 | 2015 | 154 | 0.140 |
Why?
|
Medical Informatics | 1 | 2016 | 19 | 0.140 |
Why?
|
Consumer Health Information | 1 | 2016 | 22 | 0.140 |
Why?
|
Pamphlets | 2 | 2013 | 27 | 0.140 |
Why?
|
Health Services Research | 2 | 2014 | 133 | 0.140 |
Why?
|
Sex Factors | 1 | 2019 | 859 | 0.140 |
Why?
|
California | 1 | 2017 | 436 | 0.140 |
Why?
|
Body Mass Index | 3 | 2009 | 775 | 0.140 |
Why?
|
Confidentiality | 1 | 2015 | 26 | 0.140 |
Why?
|
Personality Inventory | 2 | 2009 | 73 | 0.140 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2015 | 38 | 0.140 |
Why?
|
Patient Compliance | 2 | 2007 | 202 | 0.130 |
Why?
|
Cilia | 1 | 2015 | 23 | 0.130 |
Why?
|
Morphogenesis | 1 | 2015 | 48 | 0.130 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 89 | 0.130 |
Why?
|
Estrogen Receptor Modulators | 1 | 2014 | 18 | 0.130 |
Why?
|
Protein Isoforms | 1 | 2015 | 121 | 0.130 |
Why?
|
Health Literacy | 1 | 2016 | 100 | 0.130 |
Why?
|
Models, Educational | 1 | 2014 | 41 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 528 | 0.120 |
Why?
|
Southeastern United States | 1 | 2013 | 48 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 2013 | 35 | 0.120 |
Why?
|
Health Behavior | 2 | 2010 | 491 | 0.120 |
Why?
|
Sexual Behavior | 1 | 2019 | 587 | 0.120 |
Why?
|
Cancer Care Facilities | 1 | 2013 | 15 | 0.120 |
Why?
|
Stress, Psychological | 1 | 2019 | 541 | 0.120 |
Why?
|
Patient Care | 1 | 2013 | 28 | 0.120 |
Why?
|
Spain | 1 | 2013 | 33 | 0.110 |
Why?
|
Tissue Banks | 1 | 2012 | 5 | 0.110 |
Why?
|
Animals | 5 | 2024 | 14307 | 0.110 |
Why?
|
Base Sequence | 1 | 2015 | 932 | 0.110 |
Why?
|
Patient Preference | 1 | 2013 | 46 | 0.110 |
Why?
|
Mice | 4 | 2024 | 5668 | 0.110 |
Why?
|
Family | 1 | 2013 | 162 | 0.100 |
Why?
|
Medically Underserved Area | 2 | 2011 | 98 | 0.100 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 1490 | 0.100 |
Why?
|
Insulin | 2 | 2023 | 224 | 0.100 |
Why?
|
Odds Ratio | 2 | 2016 | 517 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2011 | 188 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2015 | 570 | 0.100 |
Why?
|
Health Care Costs | 1 | 2011 | 69 | 0.100 |
Why?
|
Program Development | 1 | 2012 | 225 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 121 | 0.100 |
Why?
|
Skin Pigmentation | 1 | 2010 | 18 | 0.090 |
Why?
|
Sunlight | 1 | 2010 | 46 | 0.090 |
Why?
|
Minority Groups | 3 | 2022 | 537 | 0.090 |
Why?
|
Fear | 1 | 2012 | 234 | 0.090 |
Why?
|
Foot | 1 | 2009 | 10 | 0.090 |
Why?
|
Medicare | 2 | 2008 | 188 | 0.090 |
Why?
|
School Health Services | 1 | 2010 | 77 | 0.090 |
Why?
|
Defense Mechanisms | 1 | 2009 | 9 | 0.090 |
Why?
|
Problem Solving | 1 | 2009 | 33 | 0.090 |
Why?
|
Treatment Outcome | 2 | 2009 | 1349 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 756 | 0.080 |
Why?
|
Disabled Persons | 1 | 2008 | 60 | 0.080 |
Why?
|
Perinatology | 1 | 2006 | 2 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2007 | 166 | 0.070 |
Why?
|
Infant, Newborn | 2 | 2015 | 871 | 0.070 |
Why?
|
Feeding Behavior | 1 | 2009 | 418 | 0.070 |
Why?
|
Prospective Studies | 2 | 2021 | 1353 | 0.060 |
Why?
|
Logistic Models | 1 | 2007 | 894 | 0.060 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2024 | 4 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2024 | 33 | 0.060 |
Why?
|
Exercise | 1 | 2009 | 524 | 0.060 |
Why?
|
Exocytosis | 1 | 2023 | 45 | 0.060 |
Why?
|
Mice, Inbred NOD | 1 | 2022 | 43 | 0.060 |
Why?
|
Diet | 1 | 2009 | 747 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 77 | 0.060 |
Why?
|
Respiration | 1 | 2022 | 49 | 0.060 |
Why?
|
Mice, SCID | 1 | 2022 | 143 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 271 | 0.050 |
Why?
|
Glucose | 1 | 2024 | 217 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2023 | 181 | 0.050 |
Why?
|
Palliative Care | 1 | 2022 | 52 | 0.050 |
Why?
|
Algorithms | 1 | 2005 | 435 | 0.050 |
Why?
|
Risk Assessment | 1 | 2005 | 727 | 0.050 |
Why?
|
Blood Glucose | 1 | 2023 | 333 | 0.050 |
Why?
|
Gap Junctions | 1 | 2021 | 37 | 0.050 |
Why?
|
Research Personnel | 1 | 2022 | 133 | 0.050 |
Why?
|
Proteomics | 1 | 2024 | 302 | 0.050 |
Why?
|
Prognosis | 2 | 2014 | 707 | 0.050 |
Why?
|
Principal Component Analysis | 2 | 2011 | 79 | 0.050 |
Why?
|
Cell Communication | 1 | 2021 | 93 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2024 | 897 | 0.050 |
Why?
|
Workload | 1 | 2000 | 22 | 0.050 |
Why?
|
Direct Service Costs | 1 | 2000 | 1 | 0.050 |
Why?
|
Costs and Cost Analysis | 3 | 2011 | 54 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2023 | 341 | 0.050 |
Why?
|
Cost of Illness | 1 | 2020 | 79 | 0.050 |
Why?
|
Syndrome | 1 | 2019 | 72 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2022 | 841 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2021 | 550 | 0.040 |
Why?
|
Information Services | 1 | 2018 | 14 | 0.040 |
Why?
|
Agriculture | 1 | 2018 | 45 | 0.040 |
Why?
|
Peer Group | 1 | 2018 | 138 | 0.040 |
Why?
|
Narration | 1 | 2016 | 27 | 0.040 |
Why?
|
Communication Barriers | 1 | 2015 | 53 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 18 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2015 | 99 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 143 | 0.030 |
Why?
|
Poverty | 1 | 2016 | 316 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 423 | 0.030 |
Why?
|
Translating | 1 | 2011 | 16 | 0.030 |
Why?
|
Government Programs | 1 | 2011 | 28 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 118 | 0.030 |
Why?
|
Child, Preschool | 1 | 2015 | 1318 | 0.020 |
Why?
|
Health Promotion | 1 | 2016 | 588 | 0.020 |
Why?
|
Sunscreening Agents | 1 | 2009 | 9 | 0.020 |
Why?
|
Linear Models | 1 | 2010 | 253 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 1961 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 2008 | 12 | 0.020 |
Why?
|
Fee-for-Service Plans | 1 | 2008 | 16 | 0.020 |
Why?
|
SEER Program | 1 | 2008 | 87 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2008 | 82 | 0.020 |
Why?
|
Regression Analysis | 1 | 2007 | 429 | 0.020 |
Why?
|
Pennsylvania | 1 | 2005 | 41 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2005 | 24 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2008 | 336 | 0.020 |
Why?
|
Cohort Studies | 1 | 2005 | 1422 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2000 | 61 | 0.010 |
Why?
|
Georgia | 1 | 2000 | 155 | 0.010 |
Why?
|
Data Collection | 1 | 2000 | 188 | 0.010 |
Why?
|
Community Health Services | 1 | 2000 | 175 | 0.010 |
Why?
|